Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases
Authors:
- 29 June 2020
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 9 (16) , e2000336
Abstract
Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In response to this and other worldwide health epidemics, nanomedicine has emerged as a rapidly evolving discipline that involves the development of innovative nanomaterials and nanotechnologies and their applications in therapy and diagnosis. Nanomedicine presents unique advantages over conventional medicines due to the superior properties intrinsic to nanoscopic therapies. Once used mainly for cancer therapies, recently, tremendous progress has been made in nanomedicine that has led to an overall improvement in the treatment and diagnosis of CVDs. This review elucidates the pathophysiology and potential targets of atherosclerosis and associated ischemic diseases. It may be fruitful to pursue future work in the nanomedicine‐mediated treatment of CVDs based on these targets. A comprehensive overview is then provided featuring the latest preclinical and clinical outcomes in cardiovascular imaging, biomarker detection, tissue engineering, and nanoscale delivery, with specific emphasis on nanoparticles, nanostructured scaffolds, and nanosensors. Finally, the challenges and opportunities regarding the future development and clinical translation of nanomedicine in related fields are discussed. Overall, this review aims to provide a deep and thorough understanding of the design, application, and future development of nanomedicine for atherosclerosis and related ischemic diseases.Keywords
Funding Information
- Shanghai Jiao Tong University (ZH2018ZDA36, 19X190020006)
- Shanghai Jiao Tong University
This publication has 223 references indexed in Scilit:
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery systemInternational Journal of Pharmaceutics, 2012
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct ReprogrammingCell Stem Cell, 2012
- Perspectives and opportunities for nanomedicine in the management of atherosclerosisNature Reviews Drug Discovery, 2011
- PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunityEuropean Journal of Immunology, 2010
- Aptamer based surface enhanced Raman scattering detection of vasopressin using multilayer nanotube arraysBiosensors and Bioelectronics, 2010
- Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarctionBiochemical and Biophysical Research Communications, 2010
- Macrophage death and defective inflammation resolution in atherosclerosisNature Reviews Immunology, 2009
- Shear‐regulated uptake of nanoparticles by endothelial cells and development of endothelial‐targeting nanoparticlesJournal of Biomedical Materials Research Part A, 2009